chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had pain in the same arm.  She had a knot in the muscle in her forearm, and she has numbness in her hand and fingers.
Right leg swelling; admitted for 3 days for cellulitis. Questionable large local reaction to DTaP #5.
Information has been received from a physician concerning a female who was vaccinated with a 0.5 ml first dose of Gardasil (date not reported). There was no concomitant medication. Subsequently, the patient "experienced dizziness and fainted" after receiving Gardasil. While in the physician's office it was reported that the patient also experienced "hypotensiveness". The office called 911. The patient went to the hospital and was released after four hours. Subsequently, the patient recovered. The reporting physician considered dizziness, hypotensiveness and fainting to be immediately life-threatening events. Additional information has been requested.
Patient experienced bilateral mostly elbow and some wrist and shoulder stiffness and pain. The symptoms improved after 2 days but then returned 2-3d after that and have been stable until she was seen in the clinic 14 days after receiving the vaccine. She reports dull pain "feels like in her veins" deep in her upper extremities. She reports subjective weakness but strength is normal on physical exam. She denies numbness or loss sensation.
My left calf became red swollen & tender to touch.  It hurt when I walked & couldn't sleep on my left side to painfull. I had the shot on 3/27/21 & went to dr. on Mon 3/29/21,  He  put me on blood thinners Xarelto 4- 10mg & scheduled me for ultrasound next day.  i have to be on blood thinners for 45 days & go back to dr on 5/10/21.
About two hours after vaccine, severe dry mouth continued for about 12 hours. At exactly 12 hours after vaccine, muscle aches, fatigue, chills, nausea all lasted for about 3 days. First menstrual cycle after vaccine, which occurred in august, was extremely heavy. It lasted about 10 days and was almost uncontrollable, accompanied by anemia. This is absolutely not normal while being on a well managed birth control regimen. September cycle was also heavier  and longer, but not as bad.
Nauseous, tight throat, red swollen eyes, fever, coughing, runny nose, spinning head, muscle aches, head ache.
she is diabetic; Fever; Chills; Upset stomach; Fatigue; couldn't eat; Sick for two days; couldn't go to work; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced fever, chills, upset stomach, fatigue, couldn't eat, sick for two days and couldn't go to work on an unspecified date. The patient also reported that she is diabetic on an unspecified date. The outcome of the event was unknown.  Follow-up attempts completed. No further information is expected.
Medication Error:  Client requested Janssen Covid-19 vaccine and received Pfizer Covid-19 vaccine in error.  RN who administered vaccine spoke with client and explained the error. Client stated understanding of needing to return for 2nd dose in 3 weeks. No adverse effects have been reported by client to this facility. Per  policy, a  report is required to be completed
Pain in muscle area on top. Pain went on until 2am and went down to the elbow.
Pt reports next day hands started itching, then arms, has itching in all limbs and mild rash
I had injection site soreness for a day after receiving the vaccine. I began not feeling well with cold like symptoms on 11/20/2022. I tested positive for COVID-19 on 11/21/2022. I went to an urgent care center to be tested again and it was confirmed that, I was positive. I contacted my doctor and got a prescription for Paxlovid and a cough syrup.
Pain to left arm. Redness and swelling and heat to injection site. Itching to site. Dizziness and lightheadedness. Symptoms began approx. 3 hours following injection and have gotten worse over last 48 hours.
Patient's arm was red and swollen which began about 24 hrs after vaccination. Patient did not have reaction after first dose.
Immediately after the shot, I sat down and became hot, sweaty and dizzy.  After a few moments, I had a seizure in the waiting room of the pharmacy while sitting in the chair.  Pharmacists and former EMT were in the vicinity to help immediately.  I was then taken by ambulance to the hospital.
I couldn't walk/hard time moving around/wobbly and had to hold onto the walls and furniture; Dizzy; Felt very exhausted; This spontaneous case was received on 08-Feb-2021 from other non-health professional via Agency (reference number: SEQW21-00439) and concerned an elderly female patient of unspecified age, in her 70s.  The patient's concurrent conditions included asthma. The patient's concomitant medications were not reported. The patient's historical vaccine included influenza virus vaccine after which the patient experienced general achiness all over and soreness in her arm (see case 202101376).  On 01-Oct-2020, the patient was vaccinated with Fluad Quadrivalent vaccine (influenza vaccine, inactivated influenza virus surface antigen (subunit), egg-derived, mf59; dose: 0.5 ml, anatomical location: left arm and route of administration: not reported) for protection against seasonal influenza. The batch number was not reported.  On 02-Oct-2020, about seven hours after receiving Fluad Quadrivalent, the patient had to get up to use the restroom and had a hard time moving around. She was very dizzy and wobbly and had to hold onto the walls and furniture on her way to the bathroom, she could not walk. This feeling lasted about 24 hours. About this time period, the dizziness subsided but the patient stated that she felt very exhausted for about two days. The patient did not use any treatment.  On an unspecified date in Oct-2020, the events eventually levelled off after the two days had passed. The patient recovered from events and she was not experiencing any adverse reactions to date.   The reporter did not provide a causality assessment.  The case was assessed as non-serious.  The case is linked to the case 202101376 (the same patient).  Company comment: An elderly female patient of unspecified age (reported to be in her 70s) experienced gait disturbance, dizziness and fatigue after vaccination with the suspect product, influenza virus vaccine polyvalent. Information regarding the concomitant medications have not been provided. Advanced age confounds causality. Nevertheless, causality is assessed as possibly related based on plausible time relationship.; Sender's Comments: An elderly female patient of unspecified age (reported to be in her 70s) experienced gait disturbance, dizziness and fatigue after vaccination with the suspect product, influenza virus vaccine polyvalent. Information regarding the concomitant medications have not been provided. Advanced age confounds causality. Nevertheless, causality is assessed as possibly related based on plausible time relationship.
Local reaction at injection sites, redness and swelling.  Swelling of tongue and complaints of tongue "itching".  Patient seen in office 24 hours after administration and treated with Benadryl and Orapred
Could not breath very good; Felt worse of the throat, felt like the throat was stuck; Felt worse of the throat, felt like the throat was stuck; Throat was sore; Dry cough; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat was sore), COUGH (Dry cough), THROAT TIGHTNESS (Felt worse of the throat, felt like the throat was stuck), RESPIRATION ABNORMAL (Could not breath very good) and CONDITION AGGRAVATED (Felt worse of the throat, felt like the throat was stuck) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (Throat was sore) and COUGH (Dry cough). On 01-Feb-2021, the patient experienced THROAT TIGHTNESS (Felt worse of the throat, felt like the throat was stuck) and CONDITION AGGRAVATED (Felt worse of the throat, felt like the throat was stuck). On 02-Feb-2021, the patient experienced RESPIRATION ABNORMAL (Could not breath very good). At the time of the report, OROPHARYNGEAL PAIN (Throat was sore), COUGH (Dry cough), THROAT TIGHTNESS (Felt worse of the throat, felt like the throat was stuck), RESPIRATION ABNORMAL (Could not breath very good) and CONDITION AGGRAVATED (Felt worse of the throat, felt like the throat was stuck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Coronavirus test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment for the event included hot tea.
It started probably that Thursday, but I am not a 100% sure I was not having any early symptoms before getting the vaccine. But I noticed on 11/18/2021 since it was worse. I went to urgent care, and they put me in Augmentin for 7 days. I saw my doctor and she increased it to 14 days. I was diagnosed with Diverticulitis, and it is actually my second time with it. She said it was not necessary to do any medical tests but if it continued then she would do some. Also, I had the flu shot on 10/02/2021.
Severe headache with migraine like features of photophobia, nausea and vomiting. Inability to keep anything down. Eye pain, and did have swelling of his lips on first day after administration of HPV. Mild Nuchal rigidity.
At 11:25 pt stated " I feel dizzy and would like to lay down". Laid pt down and placed cold pack on him. 11:27 BP: 120/80 P:86 R:20 O2 Sat 96. At 11:36 pt stated he felt better nurse had pt stay an additional 15 mins before he left the site.
Patient had 2nd dose of Moderna vaccine and within her 15 minute waiting period she became lethargic and had a decreased level of consciousness. She was lowered to the floor where she then vomited. She was placed in the recovery position and 911 was called. She was then transported vis EMS to the ER.
Information has been received from a physician concerning a 12 year old female who on 03-MAR-1999 was vaccinated with a first dose of MMR II (HSA). On 08-JAN-2002 the patient was vaccinated with a second dose MMR II (HSA). On 20-NOV-2009 the patient experienced mumps (thought the date diagnosed was reported as 27-NOV-2009). The patient was afebrile and had parotitis. The patient's outcome was unknown. Follow up information has been received reporting that the patient was previously exposure to other patients with mumps. On 16-DEC-2009 (previously reported as 20-NOV-2009) the patient experienced mumps. Mumps was diagnosed on 17-DEC-2009 (previously reported as 27-NOV-2009). The patient was afebrile and had left parotitis. At the time of the report, the patient's outcome was unspecified. No further information available.
3 or 4 days after the booster I had a red and swollen arm. I experienced lumps in my breast where I already had a mastectomy. I noticed it about the last week in November. I went to the doctor on 12/06/2021. They did an ultrasound and it showed there were 3 lumps on the side of the breast, where there was scar tissue from the mastectomy. They were not able to biopsy so they scheduled a lump biopsy on next Wednesday. I am having surgery next week so it has obviously progressed.
Fever; loss of appetite; headaches; fatigue all day; nausea; This is a spontaneous report from a contactable consumer. A 79-year-old patient of an unspecified gender received bnt162b2 (BNT162B2), dose 2 intramuscular, administered in Arm Right on 20Feb2021 (Batch/Lot Number: EN6200) at single dose for covid-19 immunisation. Medical history included Non-Hodgkin's lymphoma (4 years ago). Historical vaccine included BNT162B2, dose 1 intramuscularly, administered in Arm Right on 31Jan2021 14:00 (Batch/Lot Number: EL9265) at single dose. The concomitant medications were not reported. On 21Feb2021, the patient experienced fever, loss of appetite, headaches, fatigue all day and nausea. The patient did not receive any treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient underwent lab tests and procedures which included covid-19 negative on Jan2021. The outcome of events was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained
Acute onset rash a few hours after receiving MENVEO and quadrivalent flu vaccine. Rash on face and neck with urticaria, erythema, mild left cheek and periorbital edema, rash on neck fine papular. No rash at injection sites.
EKG, Oxygen, albuterol and epi injection administered through the emergency department.
Patient presented for her 2nd dose of the Pfizer Covid 19 vaccine. When going through the vaccination assessment the patient made it known that she tested positive for Covid in August. The nurse then asked if she was treated for Covid in which the patient replied that she was given antibodies in the hospital. The patient then went on to say she was never asked if she had been treated with a monoclonal antibody when she presented for her first dose of the Pfizer vaccine.
Started with white spots and slightly raised. Following day broke out in a body rash. Mother took pt to ER.
Headache, muscle soreness & weakness, & fatigue started 12 hours after shot & lasted 48 hours. Chills & fever started 12 hours after, lasted 12 hours. Vertigo & nausea 20 hours after, lasted 30 minutes. Injection site pain continuing 6 days after shot.
redness; little achiness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness) and PAIN (little achiness) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Medical history was not provided by the reporter.  Concomitant products included AMLODIPINE and ATORVASTATIN for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced ERYTHEMA (redness) and PAIN (little achiness). At the time of the report, ERYTHEMA (redness) and PAIN (little achiness) outcome was unknown.            No relevant concomitant medication was reported.  Treatment information was not provided.   This case was linked to MOD-2021-066945, MOD-2021-066945 (Patient Link).
aches; feeling feverish; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 68-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 06Mar2021 17:00 (Batch/Lot Number: EN6199) as SINGLE DOSE for covid-19 immunisation Medical history included pace maker, high blood pressure and macular D. The patient known allergies included tomatoes. The patient experienced aches and feeling feverish on 07Mar2021. Outcome of the events recovering.  No follow-up attempts are possible. No further information is expected.
Child noted to have 2cm x 2cm circular area with redness with hard center to (L) thigh very itchy, mildly warm to touch with mild tenderness. Cont w/ warm compresses.
Febrile seizure on 5/1/2021 with temp 101.9. Seen in ED with normal exam and discharged, No further events.
Patient was given MMR #1, PCV-13 #3, & Hib #4 on 10/19/12. Since then, she developed a rash around her face/legs/arms/abdomen. The rash is erythematous plaques with dried scaly lesions on ankles & face. she also has erythematous macules on her soles of bilateral feet.  She has a large abscess on left upper molar teeth as well  with black discoloration. This was noted 2 days ago. Pt came for evaluation today - 10/26/12.
Pt came to ER with nausea, vomiting, difficulty breathing.  Pt was coughing up blood O2 sat 90 room air initially then down to low 80's.  Put on high flow 10 L nasal cannula.  Diagnosis hypoxia, dyspnea at rest, pericarditis, elevated troponin 35.  Transferred to second hospital.  Update from them : likely myopericarditis with cardiogenic shock, respiratory failure, diffuse ST elevation on  EKG, on Inotropes
06/12/2003: Noted red, burning area right of spine on lower back.  Some mild itching, burning, achy pain radiating from area.  06/16/2003: Saw MD-shingles diagnosis.  Patient started on Viatrex, antiviral x 7 days.  Today 06/27/2003: Patch beginning to resolve.  Continues to have pain radiating from patch to front of pelvis.  Also has pain under scapula which is improving.  Also has right lbp which began 06/08/2003.  Subscapular pain began 2 weeks prior to shingles.
My daughter tested positive for Covid-19, she has been vaccinated.; My daughter tested positive for Covid-19, she has been vaccinated.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the parent.  A 16-year-old female patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EW0175), as dose 2, single (Lot number: EW0177) and on 07Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 15 years for covid-19 immunisation. The patient's relevant medical history included: "Birth control" (unspecified if ongoing). Concomitant medication(s) included: MILI [ETHINYLESTRADIOL;NORGESTIMATE] taken for contraception. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "My daughter tested positive for Covid-19, she has been vaccinated.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive.  Clinical course: Pfizer colleague (Reporter) stated, so my daughter tested positive for Covid-19, she has been vaccinated. LOT: Pfizer colleague stated, "She had three different LOT for the the different shot. First one was EW0175. the second is EW0177 and the last one is 3303 I thinks this is 6 DD.''  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
About a week or two after my second shot, I started developing constant, uncontrollable blinking. It feels like a spasm and causes other parts of my face to spasm (my jaw especially). I think it was exacerbated by my use of Zyn nicotine pouches, because the issue got better once I discontinued use. A couple weeks have passed since I stopped using this product though and the blinking/spasms persist.
Chills, fever up to 102 F, extreme sore right arm and extreme body aches all over, stiffness and neck stiffness, sleeplessness, nausea, fatigue and weakness, congestion, abdominal pain, severe headache. Lasted 36 hours approximately
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On unknown dates the patient was vaccinated with first and second dose of M-M-R II (lot #, expiration date, dose and route not reported). No concomitant medications were reported. Then on an unknown date the patient had a blood titer performed. The titer was negative for immunity to mumps. There was not treatment given. The patient's present status was unspecified. The relatedness between "titer was negative" and M-M-R II was not reported. Additional information has been requested.
My COVID-19 infection symptoms started on 03/14/2023 at 10:00. I had fever of 102.00, headache, lethargy,  nasal congestions and tiredness.  I took Sudafed, Zyrtec,  Claritin, and Mucinex  as night. I also took Tylenol for fever. I did a test that night using a home COVID-19 test which was positive. I called my doctor and  he prescribe me Lagevrio for 5 days .I had fever for 4 days. As of now I am more tired than before. I also had COVID-19 infection last year on June. I tested negative on 03/23/2023.
chills ...fever....extreme weakness, not even able to get himself up from a chair NO strength what so ever, feeling he was going to faint at any minute , slurred speech. Sounded as if he was having a stroke and extreme dizziness.So we to him to ER. Once there they did CBC with Differential...Comprehensive Metabolic Panel ..Protime-Inr....Ptt....Sugar Ck....Urinalysis with Reflex Culture  ....Then they did a CT  Head W/O Contrast Stoke Protocol & an EKG 12- lead  The report with all this information was printed out on 01/05/2021  03:03 PM
This case was reported by a pharmacist via call center representative and described the occurrence of twitching of limbs in a 70-year-old male patient who received SHINGRIX (batch number PK9BY, expiry date 19th March 2021) for prophylaxis. On 26th September 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 26th September 2018, less than a day after receiving SHINGRIX, the patient experienced twitching of limbs. On an unknown date, the patient experienced wheezing. On an unknown date, the outcome of the twitching of limbs was not recovered/not resolved and the outcome of the wheezing was not recovered/not resolved. It was unknown if the reporter considered the twitching of limbs and wheezing to be related to SHINGRIX. Additional details were provided as follows: The patient had been experiencing muscle twitching in his arm and wheezing since the administration of SHINGRIX. The muscle twitching was started on the day of the vaccination and was not sure when the wheezing started.
when vaccine was being administered, the needle disconnected from the syringe; caused some vaccine to end up on the patient's arm; incorrectly administered dose; A spontaneous report was received from a pharmacist (PharmD) concerning a 62-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced when vaccine was being administered, the needle disconnected from the syringe (device connection issue) that caused some vaccine to end up on the patient's arm (exposure via skin contact) and an incorrectly administered dose (underdose).  The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.    On 28 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (lot number: 012M20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection.   When the vaccine was being administered, the needle disconnected from the syringe.  This caused some of the vaccine to end up on the patient's arm and an incorrectly administered dose.  Treatment information was not provided.    Action taken with mRNA-1273 in response to the events was not provided.  The events, when vaccine was being administered, the needle disconnected from the syringe that caused some vaccine to end up on the patient's arm, and an incorrectly administered dose, were considered recovered/resolved on 28 Jan 2021.; Reporter's Comments: This report refers to a case of device connection issue, exposure via skin contact and underdose with no associated AEs.